Avenue Therapeutics Q1 EPS $(0.21) Up From $(0.62) YoY

Benzinga Newsdesk www.benzinga.com Negative 53.9%

Neg 53.9% Neu 0% Pos 0%

Avenue Therapeutics (OTC:ATXI) reported quarterly losses of $(0.21) per share. This is a 66.13 percent increase over losses of $(0.62) per share from the same period last year.